APO Research
Talk to an analyst

APO RESEARCH · REPORT

Candida Infection Testing

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Candida Infection Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 May 2026192 pages

Choose your research edition.

Industry ResearchCandida Infection Testing Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Candida Infection Testing Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Candida Infection Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Candida Infection Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Candida Infection Testing Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Candida Infection Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Candida Infection Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Candida Infection Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Candida Infection Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Candida Infection Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Candida Infection Testing include Roche Diagnostics, Abbott Diagnostics, bioMérieux, Becton Dickinson, Thermo Fisher Scientific, Siemens Healthineers, Bruker, Danaher and QuidelOrtho, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Candida Infection Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Candida Infection Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Candida Infection Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Candida Infection Testing market size, projected growth trends, production technologies, key applications, and end-use industries.

Candida Infection Testing Segment by Company

Roche Diagnostics

Abbott Diagnostics

bioMérieux

Becton Dickinson

Thermo Fisher Scientific

Siemens Healthineers

Bruker

Danaher

QuidelOrtho

Luminex

Hologic

Sysmex

Bio‑Rad Laboratories

Cepheid

Qiagen

ARUP Laboratories

Labcorp

Quest Diagnostics

Eurofins Scientific

Synlab

Candida Infection Testing Segment by Type

Traditional Culture

Molecular Biology Detection

Candida Infection Testing Segment by Application

Medical

Maternal and Child Health

Physical Examination

Aesthetic Medicine

Other

Candida Infection Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Candida Infection Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Candida Infection Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Candida Infection Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Candida Infection Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Candida Infection Testing industry.

Chapter 3: Detailed analysis of Candida Infection Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Candida Infection Testingrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Candida Infection Testing Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Traditional Culture Table 3. Key Players of Molecular Biology Detection Table 4. Global Candida Infection Testing Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Medical Table 6. Key Players of Maternal and Child Health Table 7. Key Players of Physical Examination Table 8. Key Players of Aesthetic Medicine Table 9. Key Players of Other Table 10. Global Candida Infection Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Candida Infection Testing Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Candida Infection Testing Market Share by Region (2021-2026) Table 13. Global Candida Infection Testing Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Candida Infection Testing Market Share by Region (2027-2032) Table 15. Candida Infection Testing Industry Trends Table 16. Candida Infection Testing Industry Drivers Table 17. Candida Infection Testing Industry Opportunities and Challenges Table 18. Candida Infection Testing Industry Restraints Table 19. Global Candida Infection Testing Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Candida Infection Testing Revenue Market Share by Company (2021-2026) Table 21. Global Candida Infection Testing Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Candida Infection Testing Key Company Head Office and Area Served Table 23. Global Candida Infection Testing Company, Product Type & Application Table 24. Global Candida Infection Testing Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Candida Infection Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Candida Infection Testing Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Candida Infection Testing Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Candida Infection Testing Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Candida Infection Testing Revenue Market Share by Type (2021-2026) Table 31. Global Candida Infection Testing Revenue Market Share by Type (2027-2032) Table 32. Global Candida Infection Testing Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Candida Infection Testing Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Candida Infection Testing Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Candida Infection Testing Revenue Market Share by Application (2021-2026) Table 36. Global Candida Infection Testing Revenue Market Share by Application (2027-2032) Table 37. Roche Diagnostics Company Information Table 38. Roche Diagnostics Business Overview Table 39. Roche Diagnostics Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Roche Diagnostics Candida Infection Testing Product Portfolio Table 41. Roche Diagnostics Recent Development Table 42. Abbott Diagnostics Company Information Table 43. Abbott Diagnostics Business Overview Table 44. Abbott Diagnostics Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Abbott Diagnostics Candida Infection Testing Product Portfolio Table 46. Abbott Diagnostics Recent Development Table 47. bioMérieux Company Information Table 48. bioMérieux Business Overview Table 49. bioMérieux Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. bioMérieux Candida Infection Testing Product Portfolio Table 51. bioMérieux Recent Development Table 52. Becton Dickinson Company Information Table 53. Becton Dickinson Business Overview Table 54. Becton Dickinson Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Becton Dickinson Candida Infection Testing Product Portfolio Table 56. Becton Dickinson Recent Development Table 57. Thermo Fisher Scientific Company Information Table 58. Thermo Fisher Scientific Business Overview Table 59. Thermo Fisher Scientific Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Thermo Fisher Scientific Candida Infection Testing Product Portfolio Table 61. Thermo Fisher Scientific Recent Development Table 62. Siemens Healthineers Company Information Table 63. Siemens Healthineers Business Overview Table 64. Siemens Healthineers Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Siemens Healthineers Candida Infection Testing Product Portfolio Table 66. Siemens Healthineers Recent Development Table 67. Bruker Company Information Table 68. Bruker Business Overview Table 69. Bruker Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Bruker Candida Infection Testing Product Portfolio Table 71. Bruker Recent Development Table 72. Danaher Company Information Table 73. Danaher Business Overview Table 74. Danaher Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Danaher Candida Infection Testing Product Portfolio Table 76. Danaher Recent Development Table 77. QuidelOrtho Company Information Table 78. QuidelOrtho Business Overview Table 79. QuidelOrtho Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. QuidelOrtho Candida Infection Testing Product Portfolio Table 81. QuidelOrtho Recent Development Table 82. Luminex Company Information Table 83. Luminex Business Overview Table 84. Luminex Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Luminex Candida Infection Testing Product Portfolio Table 86. Luminex Recent Development Table 87. Hologic Company Information Table 88. Hologic Business Overview Table 89. Hologic Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Hologic Candida Infection Testing Product Portfolio Table 91. Hologic Recent Development Table 92. Sysmex Company Information Table 93. Sysmex Business Overview Table 94. Sysmex Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Sysmex Candida Infection Testing Product Portfolio Table 96. Sysmex Recent Development Table 97. Bio‑Rad Laboratories Company Information Table 98. Bio‑Rad Laboratories Business Overview Table 99. Bio‑Rad Laboratories Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Bio‑Rad Laboratories Candida Infection Testing Product Portfolio Table 101. Bio‑Rad Laboratories Recent Development Table 102. Cepheid Company Information Table 103. Cepheid Business Overview Table 104. Cepheid Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. Cepheid Candida Infection Testing Product Portfolio Table 106. Cepheid Recent Development Table 107. Qiagen Company Information Table 108. Qiagen Business Overview Table 109. Qiagen Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. Qiagen Candida Infection Testing Product Portfolio Table 111. Qiagen Recent Development Table 112. ARUP Laboratories Company Information Table 113. ARUP Laboratories Business Overview Table 114. ARUP Laboratories Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 115. ARUP Laboratories Candida Infection Testing Product Portfolio Table 116. ARUP Laboratories Recent Development Table 117. Labcorp Company Information Table 118. Labcorp Business Overview Table 119. Labcorp Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 120. Labcorp Candida Infection Testing Product Portfolio Table 121. Labcorp Recent Development Table 122. Quest Diagnostics Company Information Table 123. Quest Diagnostics Business Overview Table 124. Quest Diagnostics Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 125. Quest Diagnostics Candida Infection Testing Product Portfolio Table 126. Quest Diagnostics Recent Development Table 127. Eurofins Scientific Company Information Table 128. Eurofins Scientific Business Overview Table 129. Eurofins Scientific Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 130. Eurofins Scientific Candida Infection Testing Product Portfolio Table 131. Eurofins Scientific Recent Development Table 132. Synlab Company Information Table 133. Synlab Business Overview Table 134. Synlab Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 135. Synlab Candida Infection Testing Product Portfolio Table 136. Synlab Recent Development Table 137. North America Candida Infection Testing Market Size by Type (2021-2026) & (US$ Million) Table 138. North America Candida Infection Testing Market Size by Type (2027-2032) & (US$ Million) Table 139. North America Candida Infection Testing Market Size by Application (2021-2026) & (US$ Million) Table 140. North America Candida Infection Testing Market Size by Application (2027-2032) & (US$ Million) Table 141. North America Candida Infection Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. North America Candida Infection Testing Market Size by Country (2021-2026) Table 143. North America Candida Infection Testing Market Size by Country (2027-2032) Table 144. Europe Candida Infection Testing Market Size by Type (2021-2026) & (US$ Million) Table 145. Europe Candida Infection Testing Market Size by Type (2027-2032) & (US$ Million) Table 146. Europe Candida Infection Testing Market Size by Application (2021-2026) & (US$ Million) Table 147. Europe Candida Infection Testing Market Size by Application (2027-2032) & (US$ Million) Table 148. Europe Candida Infection Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe Candida Infection Testing Market Size by Country (2021-2026) Table 150. Europe Candida Infection Testing Market Size by Country (2027-2032) Table 151. China Candida Infection Testing Market Size by Type (2021-2026) & (US$ Million) Table 152. China Candida Infection Testing Market Size by Type (2027-2032) & (US$ Million) Table 153. China Candida Infection Testing Market Size by Application (2021-2026) & (US$ Million) Table 154. China Candida Infection Testing Market Size by Application (2027-2032) & (US$ Million) Table 155. Asia Candida Infection Testing Market Size by Type (2021-2026) & (US$ Million) Table 156. Asia Candida Infection Testing Market Size by Type (2027-2032) & (US$ Million) Table 157. Asia Candida Infection Testing Market Size by Application (2021-2026) & (US$ Million) Table 158. Asia Candida Infection Testing Market Size by Application (2027-2032) & (US$ Million) Table 159. Asia Candida Infection Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Candida Infection Testing Market Size by Country (2021-2026) Table 161. Asia Candida Infection Testing Market Size by Country (2027-2032) Table 162. South America, Middle East & Africa Candida Infection Testing Market Size by Type (2021-2026) & (US$ Million) Table 163. South America, Middle East & Africa Candida Infection Testing Market Size by Type (2027-2032) & (US$ Million) Table 164. South America, Middle East & Africa Candida Infection Testing Market Size by Application (2021-2026) & (US$ Million) Table 165. South America, Middle East & Africa Candida Infection Testing Market Size by Application (2027-2032) & (US$ Million) Table 166. South America, Middle East & Africa Candida Infection Testing Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. South America, Middle East & Africa Candida Infection Testing Market Size by Country (2021-2026) Table 168. South America, Middle East & Africa Candida Infection Testing Market Size by Country (2027-2032) Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Candida Infection Testing Product Image Figure 2. Global Candida Infection Testing Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Candida Infection Testing Market Share by Type: 2025 VS 2032 Figure 4. Traditional Culture Image Figure 5. Molecular Biology Detection Image Figure 6. Global Candida Infection Testing Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Candida Infection Testing Market Share by Application: 2025 VS 2032 Figure 8. Medical Image Figure 9. Maternal and Child Health Image Figure 10. Physical Examination Image Figure 11. Aesthetic Medicine Image Figure 12. Other Image Figure 13. Global Candida Infection Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 15. Global Candida Infection Testing Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Candida Infection Testing Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Candida Infection Testing Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Candida Infection Testing Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Candida Infection Testing Revenue Market Share by Type (2021-2032) Figure 22. Global Candida Infection Testing Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Candida Infection Testing Revenue Market Share by Application (2021-2032) Figure 24. North America Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 25. North America Candida Infection Testing Market Share by Type (2021-2032) Figure 26. North America Candida Infection Testing Market Share by Application (2021-2032) Figure 27. North America Candida Infection Testing Market Share by Country (2021-2032) Figure 28. United States Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 29. Canada Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 31. Europe Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 32. Europe Candida Infection Testing Market Share by Type (2021-2032) Figure 33. Europe Candida Infection Testing Market Share by Application (2021-2032) Figure 34. Europe Candida Infection Testing Market Share by Country (2021-2032) Figure 35. Germany Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 36. France Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 38. Italy Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 39. Russia Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 41. China Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 42. China Candida Infection Testing Market Share by Type (2021-2032) Figure 43. China Candida Infection Testing Market Share by Application (2021-2032) Figure 44. Asia Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 45. Asia Candida Infection Testing Market Share by Type (2021-2032) Figure 46. Asia Candida Infection Testing Market Share by Application (2021-2032) Figure 47. Asia Candida Infection Testing Market Share by Country (2021-2032) Figure 48. Japan Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 52. India Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 53. Australia Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Candida Infection Testing Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Candida Infection Testing Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Candida Infection Testing Market Share by Country (2021-2032) Figure 58. Brazil Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 63. UAE Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 65. Chile Candida Infection Testing Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Traditional Culture
  • Molecular Biology Detection
Applications
  • Medical
  • Maternal and Child Health
  • Physical Examination
  • Aesthetic Medicine
  • Other
Companies covered
  • Roche Diagnostics
  • Abbott Diagnostics
  • bioMérieux
  • Becton Dickinson
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Bruker
  • Danaher
  • QuidelOrtho
  • Luminex
  • Hologic
  • Sysmex
  • Bio‑Rad Laboratories
  • Cepheid
  • Qiagen
  • ARUP Laboratories
  • Labcorp
  • Quest Diagnostics
  • Eurofins Scientific
  • Synlab

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Candida Infection Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Traditional Culture
  5. 1.2.3 Molecular Biology Detection
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Candida Infection Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Medical
  9. 1.3.3 Maternal and Child Health
  10. 1.3.4 Physical Examination
  11. 1.3.5 Aesthetic Medicine
  12. 1.3.6 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Candida Infection Testing Growth Trends by Region
  15. 1.5.1 Global Candida Infection Testing Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Candida Infection Testing Market Size by Region (2021-2026)
  17. 1.5.3 Candida Infection Testing Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Candida Infection Testing Market Dynamics
  1. 2.1 Candida Infection Testing Industry Trends
  2. 2.2 Candida Infection Testing Industry Drivers
  3. 2.3 Candida Infection Testing Industry Opportunities and Challenges
  4. 2.4 Candida Infection Testing Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Candida Infection Testing Revenue by Company (2021-2026)
  2. 3.2 Global Candida Infection Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Candida Infection Testing Key Company Head office and Area Served
  4. 3.4 Global Candida Infection Testing Company, Product Type & Application
  5. 3.5 Global Candida Infection Testing Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Candida Infection Testing Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Candida Infection Testing Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Candida Infection Testing Tier 1, Tier 2, and Tier 3
4 Candida Infection Testing Market by Type
  1. 4.1 Global Candida Infection Testing Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Candida Infection Testing Market Size by Type (2021-2032)
  3. 4.3 Global Candida Infection Testing Market Size Share by Type (2021-2032)
5 Candida Infection Testing Market by Application
  1. 5.1 Global Candida Infection Testing Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Candida Infection Testing Market Size by Application (2021-2032)
  3. 5.3 Global Candida Infection Testing Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Roche Diagnostics
  2. 6.1.1 Roche Diagnostics Company Information
  3. 6.1.2 Roche Diagnostics Business Overview
  4. 6.1.3 Roche Diagnostics Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Roche Diagnostics Candida Infection Testing Product Portfolio
  6. 6.1.5 Roche Diagnostics Recent Developments
  7. 6.2 Abbott Diagnostics
  8. 6.2.1 Abbott Diagnostics Company Information
  9. 6.2.2 Abbott Diagnostics Business Overview
  10. 6.2.3 Abbott Diagnostics Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Abbott Diagnostics Candida Infection Testing Product Portfolio
  12. 6.2.5 Abbott Diagnostics Recent Developments
  13. 6.3 bioMérieux
  14. 6.3.1 bioMérieux Company Information
  15. 6.3.2 bioMérieux Business Overview
  16. 6.3.3 bioMérieux Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 bioMérieux Candida Infection Testing Product Portfolio
  18. 6.3.5 bioMérieux Recent Developments
  19. 6.4 Becton Dickinson
  20. 6.4.1 Becton Dickinson Company Information
  21. 6.4.2 Becton Dickinson Business Overview
  22. 6.4.3 Becton Dickinson Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Becton Dickinson Candida Infection Testing Product Portfolio
  24. 6.4.5 Becton Dickinson Recent Developments
  25. 6.5 Thermo Fisher Scientific
  26. 6.5.1 Thermo Fisher Scientific Company Information
  27. 6.5.2 Thermo Fisher Scientific Business Overview
  28. 6.5.3 Thermo Fisher Scientific Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Thermo Fisher Scientific Candida Infection Testing Product Portfolio
  30. 6.5.5 Thermo Fisher Scientific Recent Developments
  31. 6.6 Siemens Healthineers
  32. 6.6.1 Siemens Healthineers Company Information
  33. 6.6.2 Siemens Healthineers Business Overview
  34. 6.6.3 Siemens Healthineers Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Siemens Healthineers Candida Infection Testing Product Portfolio
  36. 6.6.5 Siemens Healthineers Recent Developments
  37. 6.7 Bruker
  38. 6.7.1 Bruker Company Information
  39. 6.7.2 Bruker Business Overview
  40. 6.7.3 Bruker Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Bruker Candida Infection Testing Product Portfolio
  42. 6.7.5 Bruker Recent Developments
  43. 6.8 Danaher
  44. 6.8.1 Danaher Company Information
  45. 6.8.2 Danaher Business Overview
  46. 6.8.3 Danaher Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Danaher Candida Infection Testing Product Portfolio
  48. 6.8.5 Danaher Recent Developments
  49. 6.9 QuidelOrtho
  50. 6.9.1 QuidelOrtho Company Information
  51. 6.9.2 QuidelOrtho Business Overview
  52. 6.9.3 QuidelOrtho Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 QuidelOrtho Candida Infection Testing Product Portfolio
  54. 6.9.5 QuidelOrtho Recent Developments
  55. 6.10 Luminex
  56. 6.10.1 Luminex Company Information
  57. 6.10.2 Luminex Business Overview
  58. 6.10.3 Luminex Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Luminex Candida Infection Testing Product Portfolio
  60. 6.10.5 Luminex Recent Developments
  61. 6.11 Hologic
  62. 6.11.1 Hologic Company Information
  63. 6.11.2 Hologic Business Overview
  64. 6.11.3 Hologic Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Hologic Candida Infection Testing Product Portfolio
  66. 6.11.5 Hologic Recent Developments
  67. 6.12 Sysmex
  68. 6.12.1 Sysmex Company Information
  69. 6.12.2 Sysmex Business Overview
  70. 6.12.3 Sysmex Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Sysmex Candida Infection Testing Product Portfolio
  72. 6.12.5 Sysmex Recent Developments
  73. 6.13 Bio‑Rad Laboratories
  74. 6.13.1 Bio‑Rad Laboratories Company Information
  75. 6.13.2 Bio‑Rad Laboratories Business Overview
  76. 6.13.3 Bio‑Rad Laboratories Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Bio‑Rad Laboratories Candida Infection Testing Product Portfolio
  78. 6.13.5 Bio‑Rad Laboratories Recent Developments
  79. 6.14 Cepheid
  80. 6.14.1 Cepheid Company Information
  81. 6.14.2 Cepheid Business Overview
  82. 6.14.3 Cepheid Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Cepheid Candida Infection Testing Product Portfolio
  84. 6.14.5 Cepheid Recent Developments
  85. 6.15 Qiagen
  86. 6.15.1 Qiagen Company Information
  87. 6.15.2 Qiagen Business Overview
  88. 6.15.3 Qiagen Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Qiagen Candida Infection Testing Product Portfolio
  90. 6.15.5 Qiagen Recent Developments
  91. 6.16 ARUP Laboratories
  92. 6.16.1 ARUP Laboratories Company Information
  93. 6.16.2 ARUP Laboratories Business Overview
  94. 6.16.3 ARUP Laboratories Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 ARUP Laboratories Candida Infection Testing Product Portfolio
  96. 6.16.5 ARUP Laboratories Recent Developments
  97. 6.17 Labcorp
  98. 6.17.1 Labcorp Company Information
  99. 6.17.2 Labcorp Business Overview
  100. 6.17.3 Labcorp Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Labcorp Candida Infection Testing Product Portfolio
  102. 6.17.5 Labcorp Recent Developments
  103. 6.18 Quest Diagnostics
  104. 6.18.1 Quest Diagnostics Company Information
  105. 6.18.2 Quest Diagnostics Business Overview
  106. 6.18.3 Quest Diagnostics Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Quest Diagnostics Candida Infection Testing Product Portfolio
  108. 6.18.5 Quest Diagnostics Recent Developments
  109. 6.19 Eurofins Scientific
  110. 6.19.1 Eurofins Scientific Company Information
  111. 6.19.2 Eurofins Scientific Business Overview
  112. 6.19.3 Eurofins Scientific Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Eurofins Scientific Candida Infection Testing Product Portfolio
  114. 6.19.5 Eurofins Scientific Recent Developments
  115. 6.20 Synlab
  116. 6.20.1 Synlab Company Information
  117. 6.20.2 Synlab Business Overview
  118. 6.20.3 Synlab Candida Infection Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Synlab Candida Infection Testing Product Portfolio
  120. 6.20.5 Synlab Recent Developments
7 North America
  1. 7.1 North America Candida Infection Testing Market Size (2021-2032)
  2. 7.2 North America Candida Infection Testing Market Size by Type
  3. 7.2.1 North America Candida Infection Testing Market Size by Type (2021-2026)
  4. 7.2.2 North America Candida Infection Testing Market Size by Type (2027-2032)
  5. 7.2.3 North America Candida Infection Testing Market Share by Type (2021-2032)
  6. 7.3 North America Candida Infection Testing Market Size by Application
  7. 7.3.1 North America Candida Infection Testing Market Size by Application (2021-2026)
  8. 7.3.2 North America Candida Infection Testing Market Size by Application (2027-2032)
  9. 7.3.3 North America Candida Infection Testing Market Share by Application (2021-2032)
  10. 7.4 North America Candida Infection Testing Market Size by Country
  11. 7.4.1 North America Candida Infection Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Candida Infection Testing Market Size by Country (2021-2026)
  13. 7.4.3 North America Candida Infection Testing Market Size by Country (2027-2032)
  14. 7.4.4 North America Candida Infection Testing Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Candida Infection Testing Market Size (2021-2032)
  2. 8.2 Europe Candida Infection Testing Market Size by Type
  3. 8.2.1 Europe Candida Infection Testing Market Size by Type (2021-2026)
  4. 8.2.2 Europe Candida Infection Testing Market Size by Type (2027-2032)
  5. 8.2.3 Europe Candida Infection Testing Market Share by Type (2021-2032)
  6. 8.3 Europe Candida Infection Testing Market Size by Application
  7. 8.3.1 Europe Candida Infection Testing Market Size by Application (2021-2026)
  8. 8.3.2 Europe Candida Infection Testing Market Size by Application (2027-2032)
  9. 8.3.3 Europe Candida Infection Testing Market Share by Application (2021-2032)
  10. 8.4 Europe Candida Infection Testing Market Size by Country
  11. 8.4.1 Europe Candida Infection Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Candida Infection Testing Market Size by Country (2021-2026)
  13. 8.4.3 Europe Candida Infection Testing Market Size by Country (2027-2032)
  14. 8.4.4 Europe Candida Infection Testing Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Candida Infection Testing Market Size (2021-2032)
  2. 9.2 China Candida Infection Testing Market Size by Type
  3. 9.2.1 China Candida Infection Testing Market Size by Type (2021-2026)
  4. 9.2.2 China Candida Infection Testing Market Size by Type (2027-2032)
  5. 9.2.3 China Candida Infection Testing Market Share by Type (2021-2032)
  6. 9.3 China Candida Infection Testing Market Size by Application
  7. 9.3.1 China Candida Infection Testing Market Size by Application (2021-2026)
  8. 9.3.2 China Candida Infection Testing Market Size by Application (2027-2032)
  9. 9.3.3 China Candida Infection Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Candida Infection Testing Market Size (2021-2032)
  2. 10.2 Asia Candida Infection Testing Market Size by Type
  3. 10.2.1 Asia Candida Infection Testing Market Size by Type (2021-2026)
  4. 10.2.2 Asia Candida Infection Testing Market Size by Type (2027-2032)
  5. 10.2.3 Asia Candida Infection Testing Market Share by Type (2021-2032)
  6. 10.3 Asia Candida Infection Testing Market Size by Application
  7. 10.3.1 Asia Candida Infection Testing Market Size by Application (2021-2026)
  8. 10.3.2 Asia Candida Infection Testing Market Size by Application (2027-2032)
  9. 10.3.3 Asia Candida Infection Testing Market Share by Application (2021-2032)
  10. 10.4 Asia Candida Infection Testing Market Size by Country
  11. 10.4.1 Asia Candida Infection Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Candida Infection Testing Market Size by Country (2021-2026)
  13. 10.4.3 Asia Candida Infection Testing Market Size by Country (2027-2032)
  14. 10.4.4 Asia Candida Infection Testing Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Candida Infection Testing Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Candida Infection Testing Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Candida Infection Testing Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Candida Infection Testing Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Candida Infection Testing Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Candida Infection Testing Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Candida Infection Testing Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Candida Infection Testing Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Candida Infection Testing Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Candida Infection Testing Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Candida Infection Testing Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Candida Infection Testing Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Candida Infection Testing Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Candida Infection Testing Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst